Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1996
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996WO1996016173A3 Modified proteinase inhibitors
10/17/1996WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
10/17/1996WO1994017191A3 Protein fusions for the translocation of apo-proteins into the periplasmic space
10/17/1996DE19514088A1 Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen A conjugate for the treatment of Entzünduns-, infectious and / or skin diseases
10/17/1996DE19514087A1 Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active ingredient, a polyether and, if necessary, a not as foreign prestigious, native protein
10/17/1996DE19514056A1 Protein expression system regulatable by acetate, pH or oxygen
10/17/1996CA2230627A1 Hp-8 autoantigen
10/17/1996CA2218225A1 Glucagon-like peptide-2 and its therapeutic use
10/17/1996CA2218173A1 Analogs of growth hormone-releasing factor
10/17/1996CA2217977A1 Immune-evading proteins
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217901A1 Phycobilisomes, derivatives, and uses therefor
10/17/1996CA2217816A1 Method for producing a highly enriched population of osteoclast cells
10/17/1996CA2217025A1 New chemokine expressed in eosinophils
10/17/1996CA2215389A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996CA2215141A1 Transgenic tomato plants containing a fusarium resistance gene
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/16/1996EP0737752A2 Fermentation media and methods for controlling norleucine content in polypeptides
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737749A1 Plants with modified stamen cells
10/16/1996EP0737746A2 Production of recombinant polypeptides by bovine species and transgenic methods
10/16/1996EP0737690A2 Antihypertensive agent and method for preparing same
10/16/1996EP0737314A1 Novel uses for gal4-receptor constructs
10/16/1996EP0737252A1 Gene therapy vector for the treatment of low or defective red blood cell production
10/16/1996EP0737249A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737232A1 Modular design and synthesis of aminimide containing molecules
10/16/1996EP0737209A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
10/16/1996EP0737208A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
10/16/1996EP0737207A1 Inhibitors of human plasmin derived from the kunitz domains
10/16/1996EP0737206A1 Glucagon analogs with serine replacements at position 16 having antagonistic activity
10/16/1996EP0737205A1 T-cell epitopes
10/16/1996EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0737073A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
10/16/1996EP0610179B1 Target specific antibody-superantigen conjugates and their preparation
10/16/1996EP0601052B1 Therapeutic method for the treatment of iddm
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0432168B1 Genetically engineered coccidiosis vaccine
10/16/1996EP0429477B1 Synthetic vaccine against aids virus
10/16/1996EP0414755B1 Interaction system comprising a surfactant-stabilized disperse aqueous phase containing an antibody or antibody fragment
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133598A Acylated insulin
10/16/1996CN1133597A Peptide capable of inducing immune response against HIV and AIDS preventive or remedy containing the peptide
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/16/1996CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors
10/16/1996CN1133564A The Cloning of duffy blood group antigen
10/16/1996CN1133342A Antikanamycin gene originated from microbe
10/16/1996CN1133341A Adjusting and controlling factor for expression of nitrile solution deenzyme and gene thereof
10/16/1996CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926
10/16/1996CN1033035C Method for preparing interferon alpha-2 crystals
10/16/1996CN1033034C Method for preparation of crystalline interleukin-4
10/16/1996CN1033003C Method of preparing toxid
10/15/1996US5565606 Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
10/15/1996US5565550 Antibodies to ICAM-2, and fragments thereof
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565548 Peptide having sequence of protective antibody-eliciting epitope and having mercapto groups linked to carrier comprising lipid vesicle containing amino moiety activated by polyaldehyde and cysteine
10/15/1996US5565519 Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
10/15/1996US5565431 Snake venom
10/15/1996US5565429 Human leucocyte elastase inhibitors; emphysema; antiarthritic agents; rheumatic diseases
10/15/1996US5565427 Stabilized factor VIII preparations
10/15/1996US5565426 Anti-aggregation, inhibtion of blood clotting
10/15/1996US5565425 Viral infection and proliferation inhibitors
10/15/1996US5565424 Vasoactive intestinal peptide antagonists useful as antitumor and anticancer agents
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996US5565358 Enhancer and silencer sequences isolated from the GPIIB promoter
10/15/1996US5565351 Reducing the muscle protein loss by reducing proteolysis
10/15/1996US5565350 Compounds and methods for site directed mutations in eukaryotic cells
10/15/1996US5565349 Isolated from slime molds; useful in removing dipeptides from n-terminus of genetically engineered peptides
10/15/1996US5565338 Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
10/15/1996US5565336 Nucleic acid molecule which codes a human interleukin mutein with increased activity and having a phenylalanine residue at position 171 replaced by leucine and a leucine residue at position 175 replaced by methionine
10/15/1996US5565335 Adhesion variants
10/15/1996US5565331 Nucleic acids encoding neural axon outgrowth modulators
10/15/1996US5565330 Method for removing N-terminal dipeptides from precursor polypeptides with dipeptidylaminopeptidase from Dictyostelium discoideum
10/15/1996US5565327 Detecting hyperphosphorylation of kinase substrate
10/15/1996US5565323 Determination of mutations in sequence of mitochrondial cytochrome oxidase genes which indicate presence or risk of alzheimer*s disease
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/15/1996US5565319 Enzyme-linked immunosorbent assay comprising solid phase coated with viral antigen to which antibodies in sample will bind, detectable label conjugate which will bind to antibodies
10/15/1996US5565204 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
10/15/1996US5565200 Pharmaceutical preparations derived from korean mistletoe
10/15/1996US5565186 Transgenic mouse having genome comprised of native mouse gene having some codons replaced with corresponding human codons, rendering mouse susceptible to infection with prions which cause disease in humans
10/15/1996CA2111092C Specifically beta-beta cross-linked hemoglobins and method of preparation
10/15/1996CA2067498C Composition for inducing granulocyte production or b cell production in peripheral blood
10/15/1996CA1338642C Bacterial methionine n-terminal peptidase
10/14/1996CA2174025A1 Agents modulating the response of neuronal cells to inhibition by mammalian central nervous system myelin
10/10/1996WO1996031625A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031608A1 Plant pathogen resistance genes and uses thereof
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031606A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031603A2 Methods and compositions for regulating fadd
10/10/1996WO1996031602A1 Retroviral vectors
1 ... 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 ... 2916